Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model
K. Yeon Choi, Nadia S. El‐Hamdi, Alistair McGregor
Topics & Concepts
VirologyBiologyVirusNeutralizing antibodyViral entryAntibodyImmunologyViral replicationCytomegalovirus and herpesvirus researchHerpesvirus Infections and TreatmentsParvovirus B19 Infection Studies